These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3161934)

  • 21. Foetal exposure to low doses of cyproterone acetate in the rat leads to functional endocrine abnormalities despite normal sexual morphogenesis.
    Gómez F; Monnier B; Lemarchand-Béraud T
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):411-9. PubMed ID: 6331040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open randomized comparative study of an oral contraceptive containing ethinyl estradiol and cyproterone acetate with and without the GnRH analogue goserelin in the long-term treatment of hirsutism.
    Vegetti W; Testa G; Maggioni P; Motta T; Falsetti L; Crosignani PG
    Gynecol Obstet Invest; 1996; 41(4):260-8. PubMed ID: 8793497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-androgen treatment of hirsutism with cyproterone acetate].
    Kása M; Egyedi K; Raffai S; Török L
    Z Hautkr; 1990 Dec; 65(12):1112-4. PubMed ID: 2150902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyproterone acetate, testosterone, LH, FSH, and prolactin levels in plasma after intramuscular application of cyproterone acetate in patients with prostatic cancer.
    Rost A; Schmidt-Gollwitzer M; Hantelmann W; Brosig W
    Prostate; 1981; 2(3):315-22. PubMed ID: 6458025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women.
    Frölich M; Vader HL; Walma ST; De Rooy HA
    J Steroid Biochem; 1980 Jan; 12():499-501. PubMed ID: 6448324
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of cyproterone acetate therapy on gonadotropin response to synthetic luteinizing hormone-releasing hormone (LRH) in girls with idiopathic precocious puberty.
    Angeli A; Boccuzzi G; Bisbocci D; Fonzo D; Frajria R; DeSanctis C; Ceresa F
    J Clin Endocrinol Metab; 1976 Mar; 42(3):551-60. PubMed ID: 767354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptives and pituitary response to GnRH: comparative study of progestin-related effects.
    Römmler A; Baumgarten S; Moltz L; Schwartz U; Hammerstein J
    Contraception; 1985 Mar; 31(3):295-303. PubMed ID: 3158477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evaluation of the role of androgens in hirsutism and the use of a new anti-androgen "cyproterone acetate" for therapy.
    Ismail AA; Davidson DW; Souka AR; Barnes EW; Irvine WJ; Kilimnik H; Vanderbeeken Y
    J Clin Endocrinol Metab; 1974 Jul; 39(1):81-95. PubMed ID: 4835125
    [No Abstract]   [Full Text] [Related]  

  • 30. Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals.
    Asscheman H; Gooren LJ; Assies J; Smits JP; de Slegte R
    Clin Endocrinol (Oxf); 1988 Jun; 28(6):583-8. PubMed ID: 2978262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate.
    Varenhorst E; Wallentin L; Carlström K
    Scand J Urol Nephrol; 1982; 16(1):31-6. PubMed ID: 6211762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medium-dose oral cyproterone acetate therapy in women with moderate androgenization. Results of a multicenter double-blind study].
    Moltz L; Kaiser E
    Geburtshilfe Frauenheilkd; 1984 Jan; 44(1):47-52. PubMed ID: 6230282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of cyproterone acetate on serum testosterone, LH, FSH, and prolactin in male sexual offenders.
    Jeffcoate WJ; Matthews RW; Edwards CR; Field LH; Besser GM
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):189-95. PubMed ID: 6777092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cyproterone acetate. 15 cases of hirsutism treated for 1 year].
    Houdent C; Kuhn JM; Balacheff O; Leclerc P; Legrand A; Wolf LM
    Ann Endocrinol (Paris); 1983; 44(6):397-401. PubMed ID: 6234850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
    Luboshitzky R; Herer P; Shen-Orr Z
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the cyproterone acetate + ethynil oestradiol antiandrogen association on blood coagulation and fibrinolysis in hirsute women.
    Ghezzo F; Manieri C; Rodi R; Messina M; Molinatti GM
    Panminerva Med; 1981; 23(4):223-6. PubMed ID: 6212899
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of cyproterone acetate-ethinyl oestradiol treatment on adrenal function in hirsute women.
    Chapman MG; Jeffcoate SL; Dewhurst CJ
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):577-82. PubMed ID: 6299625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men.
    Føgh M; Corker CS; Hunter WM; McLean H; Philip J; Schou G; Skakkebaek NE
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):545-52. PubMed ID: 474042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental study on neuroendocrinological and immunological characteristics of the military-trained artillerymen.
    Li X; Huang WX; Lu JM; Yang G; Ma FL; Lan YT; Meng JH; Dou JT
    Chin Med J (Engl); 2012 Apr; 125(7):1292-6. PubMed ID: 22613604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: efficacy, metabolic and endocrine effects.
    van Wayjen RG; van den Ende A
    Exp Clin Endocrinol Diabetes; 1995; 103(4):241-51. PubMed ID: 7584530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.